Why is Nectar Lifesci. falling/rising?

As of 25-Jul, Nectar Lifescience Ltd is experiencing a decline in its stock price, currently at 17.08, which reflects a decrease of 0.07 or 0.41%. The stock has been underperforming, having lost 6.92% over the last four days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock's performance over various periods shows significant losses, with a 1-month return of -23.89% and a year-to-date return of -56.21%. The company is facing operating losses, a high debt-to-EBITDA ratio of 7.73, and a negative EBITDA, which collectively contribute to its weak long-term fundamentals and low profitability. Furthermore, the fact that 99.6% of promoter shares are pledged adds downward pressure on the stock price in a falling market.
In the broader market context, Nectar Lifescience Ltd has underperformed the benchmark Sensex, which has shown a slight increase of 4.25% year-to-date, while the stock has plummeted significantly. The stock's recent performance is concerning, particularly given its negative returns compared to the benchmark over the past year and three years. The falling investor participation, with a delivery volume that has decreased by 55.09% against the 5-day average, indicates a lack of confidence among investors. Overall, the combination of poor financial performance, high debt levels, and negative market sentiment has led to the stock's continued decline.